VEBIOT Neoplasmoxan: Product Profile

VEBIOT Neoplasmoxan is a named branded product for Dogs and cats; manufacturer positioning must be kept separate from independent clinical evidence.

Quarter-scored oral tablets; current official page lists a 60-tablet pack. Intended species: Dogs and cats.

The current official Polish product page lists processed plant products, vitamin E, and sodium selenite. It describes plant polyphenols but does not disclose the plant identities or quantitative amounts in the current public composition text reviewed. Older distributor descriptions must not replace the current manufacturer label.

VEBIOT markets Neoplasmoxan as complementary nutritional support for dogs and cats with diagnosed cancer, older animals, and animals considered at higher risk. The page emphasizes antioxidant protection and normal cell division and differentiation while explicitly stating that the product does not treat or prevent disease.

May be discussed only as adjunctive/supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive goal, objective review date, adverse-effect plan, and stopping rule with the veterinarian.

Bring the current label, lot, complete ingredient panel, seller and country version, and every medicine and supplement to the treating veterinarian.

The current manufacturer page documents product category, intended nutritional context, presentation, and a limited public composition. It does not provide a controlled clinical trial of the finished product showing tumor response, recurrence prevention, or survival. General polyphenol, vitamin E, selenium, or oxidative-stress literature cannot establish a product-level oncology benefit.

Selenium and vitamin E can be harmful in excess, and risk depends on total intake from diet and all supplements. The undisclosed public plant composition limits interaction screening. Review liver or kidney disease, bleeding, surgery, chemotherapy, radiotherapy, pregnancy, and duplicate antioxidants or minerals. Use the physical label and contact the manufacturer when the exact plant ingredients are clinically relevant.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The manufacturer explicitly calls Neoplasmoxan a complementary feed mixture for dogs and cats and states it has no properties to treat or prevent animal disease. No veterinary-medicinal-product authorization for cancer treatment was identified. This boundary should remain visible in the Directory.

Poland; European Union

Document the Polish/EU package, lot, full label, start date, diet, and every selenium or vitamin E source. Track appetite, vomiting, diarrhea, stool, skin or coat change, nail or hair abnormalities, activity, body weight, and treatment adherence. The veterinarian should determine whether chemistry or other laboratory monitoring is appropriate and preserve tumor-specific follow-up.